Selbyville, Delaware, May 13, 2020 (GLOBE NEWSWIRE) -- The global injectable drug delivery market is anticipated to grow profusely at a growth rate of 8.67 per cent through 2027, hitting $39.831 billion by the end of the year, owing to the increasing geriatric population and rising occurrence of auto-immune diseases such as diabetes. Speaking of which, as per the International Diabetes Federation statistics, it was recorded that in 2019, over 9.3 per cent of the population globally had diabetes, which is likely to rise to 10.2 per cent by 2030, and 10.9 per cent by the end of 2045.
The worldwide injectable drug delivery industry is fragmented into vivid types and individual market shares and sizes, and projected growth rates of these have also been enlisted in the market study. Moreover, it also points out major threats and growth prospects that are expected to impact the overall industry growth in the upcoming years. Encompassing the ongoing as well as predicted trends that are anticipated to fuel the revenue graph of injectable drug delivery across various geographies, the report also offers information of the driving factors that would impel the industry to new heights over the mentioned timeframe.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2519226/
Additionally, the prevalence of diabetes was recorded to be more in the urban area, around 10.2 per cent, while that in rural areas, high-income and low-incomes countries was approximately over 7.2 per cent, 10.4 per cent, and 1 per cent respectively. Therefore, the rising diabetes statistics worldwide is leading to the increased demand for injectable drug delivery systems.
Injectable delivery systems are used to directly administer or inject the drug into patient’s body from oral route. Initial injection devices consisted of hypodermic syringes and needles and were basically mechanical devices used for administration of drug into the body. Injectable drug delivery systems of today are designed in such a way that they can serve the patient’s needs and improve their overall experience.
However, high cost associated with the production of these system, developments in alternate drug delivery systems, and unfavorable regulations are expected to deter the overall market growth in the upcoming years. But, the development of innovative injectable system is poised to create lucrative opportunities for the industry growth.
Regional insights:
The worldwide injectable drug delivery industry is diversified into Europe, Asia Pacific, North America, Latin America, and the ME&A. Across this regional belt, Asia Pacific is expected to emerge as a hotbed for the overall injectable drug delivery industry in the upcoming years, attributing to the expanding geriatric population count in the region. More so, rise in the life expectancy of Asian people is likely to establish avenues for the injectable drug delivery market players across APAC.
Secondly, the region is also witnessing an increment in the cases of chronic diseases including cardiovascular diseases, diabetes, and auto-immune diseases, contributing to the overall market growth. Besides, mounting demand for vaccines, which has become the most preferred method of drug administration, would add to the elevating product adoption in the region.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-injectable-drug-delivery-market-2019-2027
Competitive landscape:
The global injectable drug delivery industry is highly consolidated and boasts of the presence of top notch companies including Novo Nordis A/S, Baxter, Dickinson and Company, Becton, Eli Lilly and Co., Novartis AG, Pfizer Inc., SANOFI, INJEX, and several others.
Of these, Baxter, established in 1931, is deemed to be one of the leading companies dealing with the manufacturing, development, and commercialization of hospital equipment of different disorders. The company offers its equipment to hospitals, kidney dialysis centers, research labs, and nursing homes. Baxter boasts of business presence in more than 100 countries.
Worldwide injectable drug delivery industry is fragmented on the basis of device type, end-user, route of administration, regions, and competitive landscape.
Injectable Drug Delivery Market Device Type Analysis (Revenue, USD Million, 2019-2027)
Pen injector
Auto injector
Needle-free injector
- Gas based needle free injector
- Spring based needle free injector
- Other needle-free injectors
Prefilled syringe
- Glass prefilled syringe
- Plastic prefilled syringe
Injectable Drug Delivery Market Route of Administration Analysis (Revenue, USD Million, 2019-2027)
- Subcutaneous
- Intramuscular
- Intravenous (IV)
- Other routes of administration
Injectable Drug Delivery Market End-user Analysis (Revenue, USD Million, 2019-2027)
- Clinics/ physician offices
- Ambulatory care
- Hospital
- Home-based
- Others end-user
Injectable Drug Delivery Market Regional Analysis (Revenue, USD Million, 2019-2027)
North America
- United States
- Canada
Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia-Pacific
- India
- Japan
- Australia
- New Zealand
- China
- South Korea
- ASEAN countries
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa
- United Arab Emirates
- Saudi Arabia
- South Africa
- Turkey
- Rest of Middle East & Africa
Injectable Drug Delivery Market Competitive Landscape Analysis (Revenue, USD Million, 2019-2027)
- Gerresheimer
- INJEX
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- West Pharmaceutical Services Inc.
- Novartis AG
- Novo Nordis A/S
- SCHOTT AG
- Terumo Corporation
- Becton Dickinson and Company
- Pfizer Inc
- SANOFI
- Ypsomed
- Elcam Medical
- Baxter
Table of Content:
1. GLOBAL INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONS
2.2. PORTER’S FIVE FORCES MODEL
2.3. PATENT OUTLOOK
2.4. MARKET SHARE OUTLOOK
2.5. KEY INSIGHT
2.6. KEY BUYING CRITERIA
2.7. LEGAL REQUIREMENT
2.8. REGULATORY FRAMEWORK
2.9. MARKET ATTRACTIVENESS INDEX
2.10. MARKET DRIVERS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO?INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME BASED
5.5. OTHERS END-USER
6. INJECTABLE DRUG DELIVERY MARKET – REGIONAL OUTLOOK
Related Report:
Drug Discovery Informatics Market Size and Regional Forecasts 2019-2026
Global Drug Discovery Informatics Market is valued approximately USD 1.89 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11.20% over the forecast period 2019-2026; as per new research report. Drug discovery informatics is a functional process performed by biotechnology and pharmaceutical companies that requires the generation of very large data and information. Through application of modern engineering and computational approaches the models are analyzed, visualized and simulated for pharmacological profiling.
Global Artificial Intelligence (AI) in Drug Discovery Market Size and Regional Forecasts 2020-2026
Global Artificial Intelligence (AI) in Drug Discovery Market is valued approximately at USD 260 million in 2019 and is anticipated to grow with a healthy growth rate of more than 40.7% over the forecast period 2019-2026; as per new research report. Artificial intelligence for drug discovery is a technology that uses distinct algorithms which add value in decision-making processes for drug discovery. The implementation of AI reduces the gap of researches and development in the drug manufacturing process and also help in the targeted of manufacturing of the drugs. For this reason, the biopharmaceutical industries are increasingly adopting AI technology to optimize the drug manufacturing process.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.